Dr. Baldwin’s research has concentrated on delineating the molecular basis of vascular development in the mammalian embryo as an approach to understanding the etiology of congenital heart disease. The ultimate goal of his laboratory is to exploit in utero developmental mechanisms to inform the therapies for postnatal congenital heart and vascular diseases. He is particularly focused on the role of the endocardium in ventricular trabecular and compaction as well as the role of the lymphatic system in mediating additional morbidities and mortalities of patients with CHD.

>> View Publications on PubMed